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Background/aim: Malassezia colonization, sebaceous gland activity, hormones, immune system defects, environmental factors, and
the interactions between these factors are thought to contribute to the pathogenesis of seborrheic dermatitis (SD). Zinc, an essential
element, is involved in many biological processes including the ones that contribute to the development of SD. The aim of this study is
to evaluate serum zinc levels in patients with SD.
Materials and methods: Forty-three patients with SD and 41 healthy controls were enrolled in the study. Disease activity was assessed
by the Seborrheic Dermatitis Area and Severity Index by a single dermatologist. Serum zinc levels of all subjects were evaluated.
Results: Statistically significantly lower serum zinc levels were noted in SD patients than in the control group (79.16 ± 12.17 vs. 84.88
± 13.59, respectively; P = 0.045).
Conclusion: The results of the study demonstrated that patients who had SD had lower levels of serum zinc levels than healthy subjects.
Key words: Immune system, inflammation, seborrheic dermatitis, zinc

1. Introduction
Seborrheic dermatitis (SD) is a chronic inflammatory
skin disease localized to areas rich in sebaceous glands,
such as the scalp, face, upper chest, and back [1]. Various
factors contribute to the pathogenesis of SD, including
hormonal factors, comorbidities (associated diseases),
individual immunological features, inflammatory status,
and nutritional, environmental, and lifestyle factors, but
the exact etiology of the disease has not been clarified [2].
Zinc is a mineral involved in many biological
processes, including immune functions and metabolic and
hormonal pathways. It may play a role in the different steps
of the cutaneous inflammatory reactions, inhibiting the
chemotaxis of neutrophils, activating natural killer (NK)
cells, and modulating the production of proinflammatory
cytokines. In addition, zinc displays antioxidant and
antiandrogen activity [3]. Zinc is considered a contributor
in the pathogenesis of several inflammatory skin diseases
associated with innate immunity dysregulation, such as
inflammatory acne, folliculitis decalvans, and hidradenitis
suppurativa (HS) [4]. It has been reported that patients
with severe acne and HS have lower serum zinc levels
than the healthy population [5–8]. Moreover, SD-like

dermatitis has also been reported to be associated with zinc
deficiency [9,10]. Among many functions, zinc also plays a
role in some of the biological processes that contribute to
the development of SD. However, no reports are available
investigating serum zinc levels in patients with SD.
The aim of this study was to determine the association
between SD and serum zinc levels.
2. Materials and methods
The study was reviewed and approved by the local ethics
committee (protocol number: 22481095-020-1958, date
of approval: 19/09/2018), and all individuals gave written
informed consent. The study was carried out according to
the principles expressed in the Declaration of Helsinki.
A prospective case-control study was designed to
investigate the relationship between serum zinc levels and
SD. Forty-three patients diagnosed with SD by clinical
or histopathological examination were recruited from
a dermatology outpatient clinic. For comparison, 41
healthy age- and sex-matched controls with no evidence
of SD were recruited from among hospital staff volunteers.
Only those with a normal body mass index (BMI) (18.5–
25 kg/m2) were included. Subjects taking zinc salts or

* Correspondence: ezgiaktasmd@gmail.com

This work is licensed under a Creative Commons Attribution 4.0 International License.

1503

AKTAŞ KARABAY and AKSU ÇERMAN / Turk J Med Sci
multivitamins containing zinc, or under any systemic
treatment, including corticosteroids, retinoids, antifungal
agents, and immunosuppressants within 6 months of
the study, were excluded. Subjects with a history of any
disease or condition that can present with serum zinc
level alterations, such as inflammatory acne, folliculitis
decalvans, enteropathic acrodermatitis, malabsorptive
diseases, malnutrition, strict diet, or high alcohol
consumption (more than 20 g/day for women and more
than 30 g/day for men) [11], were also excluded. Subjects
with any inflammatory conditions that may be associated
with immune disruption, such as inflammatory bowel
disease, rheumatoid arthritis, ankylosing spondylitis,
psoriasis, and any other systemic diseases (e.g., diabetes
mellitus, parathyroid or thyroid disorders, autoimmune
diseases, anemia, atopy, chronic renal or liver disease, and
malignancy), as well as currently pregnant or lactating
females and smokers, were also excluded. The data on
smoking relied on self-reports.
The data on baseline demographics, clinical
characteristics, and blood test results were obtained on
the same day. Serum zinc levels were measured in all
subjects using fasting venous blood samples. Venous
blood samples were drawn from the participants between
the hours of 09:00 and 11:00 AM following a 12-h fasting
period. The measurements of serum zinc levels were taken
with an atomic absorption spectrophotometric system
(PerkinElmer, Norwalk, CT, USA). Normal values were
defined as those above 60 µg/dL and below 120 µg/dL.
SD was graded according to the SD Area and Severity
Index (SDASI), which was modified from the Psoriasis
Area Severity Index (PASI) established by Cömert et
al. [12]. The SDASI was calculated at the time of blood
collection by a single dermatologist. According to this
scoring system, the erythema and desquamation of nine
different anatomical sites were graded on a scale between
0 and 3, where 0 = none, 1 = mild, 2 = moderate, and
3 = severe. The score of each site was multiplied by the
constant for the area (forehead [0.1], scalp [0.4], nasolabial
[0.1], eyebrow [0.1], postauricular [0.1], auricular [0.1],
intermammary [0.2], back [0.2], and cheek or chin [0.1]),
and the sum was determined as the SDASI score (range:
0–12.6) [12].
2.1. Statistical analysis
The Number Cruncher Statistical System 2007 program
(NCSS; Kaysville, UT, USA) was used for statistical
analysis. Descriptive data were expressed with mean ±
standard deviation, numeric variables, and percentages. In
the analysis of normally distributed variables, the Shapiro–
Wilk test and graphical analysis were applied to examine
the differences between the two groups. In the analysis of
normally distributed variables, an independent samples
t-test was applied to examine the differences between
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the two groups. The Pearson chi-square test was used to
compare categorical variables. Correlation analysis was
performed by calculating Pearson and Spearman rank
correlations. Diagnosis and treatment tests (sensitivity,
specificity, positive predictive value, and negative
predictive value) and ROC analysis were used to define
predictive values. P < 0.05 was considered statistically
significant.
3. Results
A total of 43 patients with SD and 41 healthy control
subjects were included in the study. No significant
differences were observed in the sex ratio or ages between
the patients with SD and healthy controls (P > 0.05). The
mean disease duration among the SD patients was 17.49 ±
21.49 months, ranging from 1 to 120 months. The SDASI
scores of the patients ranged from 0.8 to 6.6, with a mean
of 2.79 ± 1.26.
Statistically significantly lower serum zinc levels were
noted in SD patients than in the control group (79.16 ±
12.17 vs. 84.88 ± 13.59, respectively; P = 0.045).
The clinical characteristics of the study group are
shown in Table 1.
In ROC curve analysis, the cutoff value for serum zinc
levels was assessed as 79 µg/dL with a sensitivity of 58.14%
and a specificity of 73.17%. The positive predictive value
was 69.4 and the negative predictive value was 62.5 (Table
2; Figure). No correlations were found between serum zinc
levels and disease duration (P = 0.658) or SDASI scores (P
= 0.273) (Table 3).
4. Discussion
SD is a chronic inflammatory disease of the skin
characterized by erythematous, oily, yellow squames that
are located on sebum-rich areas, such as the face or the
forehead [13]. Although the exact etiology of the disease is
unknown, increased sebum activity, Malassezia infection,
immunological abnormalities, androgens, emotional
stress, diet, lifestyle, and environmental factors are thought
to contribute to the pathogenesis of the disease [14].
The male dominancy of SD and the development of
SD during puberty may indicate a significant effect of
hormones, namely androgens, in the pathogenesis of the
disease [15].
Sebaceous gland activity is thought to be correlated
with SD development. The level of sebum production
and abnormalities of lipid composition are thought to
play a role in SD development and also provide a suitable
environment for Malassezia growth [16].
Malassezia, a fungal component of normal human
skin, is thought to play a role in the pathogenesis of SD
[17]. Since it is a lipid-dependent microorganism, it
is found on sebum-rich areas of the skin, similar to the
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Table 1. Demographic data of the subjects.
Group

Age (years)
Sex
Serum zinc levels (µg/dL)

Test value

Total

SD patients
(n = 43)

Control
(n = 41)

P

Min–max (median)

19−53 (29.5)

20−44 (28)

19−53 (31)

t: –1.703

Mean ± SD

30.60 ± 6.37

29.44 ± 4,90

31.80 ± 7.49

a

Female

38 (45.2)

19 (44.2)

19 (46.3)

χ2: 0.039

Male

46 (54.8)

24 (55.8)

22 (53.7)

b

Min–max (median)

50−126 (81.5)

50−105 (77)

63−126 (82)

t: –2.033

Meant ± SD

81.95 ± 13.12

79.16 ± 12.17

84.88 ± 13.59

a

0.093
0.843

0.045*

Student t-test, bPearson chi-square test, *P < 0.05.
SD: Seborrheic dermatitis.
a

Table 2. Diagnostic scan and ROC curve results of serum zinc levels in seborrheic dermatitis.
Diagnostic scan

Serum zinc levels (µg/dL)

ROC curve

Cut off Sensitivity Specificity

Positive
Negative
Area
predictive value predictive value

95% confidence
interval

P

≤79

69.4

0.502−0.744

0.044*

58.14

73.17

62.5

0.623

*P < 0.05.

involvement sites of SD [18]. Malassezia hydrolyzes sebum
triglycerides into unsaturated fatty acids, such as oleic acid
and arachidonic acid, by its lipase [19]. The metabolites of
the yeasts induce inflammation with the infiltration of NK
cells and macrophages and an increased local production
of inflammatory cytokines such as interleukin (IL)-1α, IL1β, IL-6, and tumor necrosis factor (TNF)-α in lesional
skin areas. These metabolites stimulate keratinocyte
differentiation, leading to abnormalities in the stratum
corneum that result in disruptions of the epidermal barrier
function and inflammatory response [20,21].
Some evidence suggests that impairment in
the epidermal barrier function due to altered
corneodesmosomal hydrolysis, lipid disorganization, and
abnormalities in the desquamation process also contribute
to the pathogenesis of SD [20,21].
SD has been reported to be more common in
immunosuppressed patients, particularly those with HIV/
AIDS [13]. The immune or inflammatory individual
response to Malassezia was also considered a contributory
factor [16,22]. Moreover, the levels of human leukocyte
antigens (HLAs), including HLA-AW30, HLA-AW31,
HLA-A32, HLA-B12, and HLA-B18, were reported to
be elevated in SD patients [22], in addition to reports of
increased levels of total serum IgA and IgG antibodies [23],

suggesting the potential immune mechanisms involved in
the pathogenesis of the disease.
The genetic components of SD have been studied
in animal models and humans [13]. Zinc finger 750
(ZNF7509) is a transcription factor controlling epidermal
differentiation and an upstream regulator of MPZL3.
Autosomal dominantly inherited SD-like dermatitis has
been identified in a frameshift mutation in ZNF750 [24].
The functional pathway of ZNF750-MPZL3 has been
suggested to play an important role in the pathogenesis of
SD [25].
Nutritional deficiencies, particularly of riboflavin,
pyridoxine, niacin, and zinc, can also present as SD-like
dermatitis by an unknown mechanism [9,10]. Although
the exact pathogenesis is still unclarified on the basis of
several studies, SD is considered a multifactorial disease,
with immune, inflammatory, and environmental factors
contributing.
Zinc is an essential element for the proper functioning
of several processes in the human body. Among these, zinc
plays a role in a number of skin disorders [26]. In both
acquired and inherited forms of hypozincemia, cutaneous
findings, including periorificial and acral dermatitis,
alopecia, diaper rash, photosensitivity, nail dystrophy,
angular stomatitis, angular cheilitis, eczematous annular
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Table 3. Relationship between serum zinc levels and disease
duration and SDASI.
Serum zinc levels
Disease duration (months)
SDASI

r

0.070c

P

0.658

r

–0.171d

P

0.273

r = Spearman rank correlation, dr = Pearson rank
correlation.
SDASI: Seborrheic Dermatitis Area and Severity Index.
c

Figure. ROC curve analysis of serum zinc levels in SD

plaques in areas of friction and pressure, dystrophic nails,
structural hair changes, and diminished growth of both
hair and nails, have been reported [27,28]. Zinc deficiency
is reported in some inflammatory skin disorders, including
atopic dermatitis [29], oral lichen planus [30], and Behçet’s
disease [31], and in autoimmune bullous diseases such
as pemphigus vulgaris [32], bullous pemphigoid [33],
epidermolysis bullosa [34], and melasma [35]. It is thought
that zinc plays a role in the development of these disorders
via its effects on the immune system [36]. Also, lower
serum zinc levels have been shown to be associated with
the occurrence of acne vulgaris [6,37]. In a recent review,
zinc was reported to be effective in the treatment of acne
vulgaris [26].
Among various functions, zinc plays a role in many
processes that may affect the development of SD [6,38–43].
Zinc affects the regulation of protein, lipid, and nucleic
acid metabolism, acting as a cofactor in metalloenzymes
and transcription factors. Zinc also plays a role in gene
transcription via a zinc-finger motif containing proteins
and factors. It also regulates cell replication, immune
activity, and wound repair. Zinc provides proper immune
activity by preserving macrophage and neutrophil
function and by stimulating NK cell and complement
activity. Zinc also has antiinflammatory effects through the
inhibition of IL-6, TNF-α, nitric oxide, and integrin and
toll-like receptor expression by keratinocyte production
[6,41]. Additionally, the zinc finger-transactivating
protein A20 inhibits IL-1b and tumor necrosis factor-α
activation of nuclear factor (NF)-kB [43]. Moreover,
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zinc has antiandrogenic activity through the inhibition
of 5α-reductase, which is the enzyme responsible for the
conversion of testosterone to dihydrotestosterone. This
also results in the suppression of sebaceous activity [6,43].
All the biologic processes mentioned above also
occur in the development of SD [9–20]. We believe that
zinc deficiency may play a role in the pathogenesis of the
disease through various mechanisms. Additionally, topical
zinc combinations have been reported to be effective in
the treatment of SD [44]. Pierard et al. [44] reported that
topical zinc formulation may be effective in the treatment
of SD through the modulation of epithelial differentiation,
antiinflammatory and antibacterial activity, and the
inhibition of 5α-reductase, which provides antiandrogen
activity [44].
Since most of the mechanisms involved in the
development of SD are related to the functions of zinc, we
hypothesized that SD patients may have zinc deficiency or
lower zinc levels. The results of the study demonstrated
that patients who had SD also had lower levels of serum
zinc levels compared with healthy subjects. However,
in the present study, serum zinc levels did not show any
correlation with disease severity, which was presented as
SDASI scores. We believe that there are two reasons for
that: the sample size was small, and the patients included
in the study had mild SD symptoms. It is known that 12.6
is the highest SDASI score that can be measured [12]; the
highest SDASI score assessed in this study group was 6.6,
while the mean score was 2.79 ± 1.26, which might be
considered a very mild presentation of SD.
The patients enrolled in the study had mild or moderate
forms of SD, which could be considered a limitation of
the study. In studies conducted with patients with higher
SDASI scores, the results might vary dramatically, perhaps
demonstrating zinc deficiency. Small sample size is another
limitation of the study.
In conclusion, zinc has many properties that affect
inflammatory processes, the immune system, and

AKTAŞ KARABAY and AKSU ÇERMAN / Turk J Med Sci
epithelial differentiation, and it has antifungal properties
and antiandrogenic effects, all of which also contribute
to the pathogenesis of SD. Based on these data and
the reports of SD-like dermatitis development in zincdeficient individuals, we hypothesized that SD patients
might have lower serum zinc levels than those without

the disease. To date, no data are available on serum zinc
levels in SD. The present study revealed lower zinc levels
in SD patients compared with controls. Further research
on the association of zinc levels and SD will help identify
the pathogenesis of the disease and help develop more
efficacious disease management.
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